New Stock News | Guoyi Medical Technology's IPO prospectus has become invalid.

Anhui Zhongji Guoyi Medical Technology Co., Ltd. (referred to as "Guoyi Technology") submitted its Hong Kong IPO prospectus on January 21, 2026, which expired after 6 months on July 21, 2026, with Haitong International Capital Limited as its exclusive sponsor. According to the prospectus, Guoyi Technology is the leader in the Chinese third-party SPD solution market, consisting of three core components: SPD software systems, intelligent hardware, and professional services. Currently, the company's SPD solutions cover the procurement, warehousing, distribution, and usage management of medical supplies, helping hospitals reduce operating costs and improve supply management efficiency. According to a report by Frost & Sullivan, based on revenue in 2024, Guoyi Technology is the largest third-party SPD solution provider in China, with a market share of 29.2%. According to the same report, the company is also the first third-party SPD solution provider in China.